人工耳蜗故障与再植入:30年分析及文献综述
该研究回顾性分析单中心1988年1月至2017年3月共804例人工耳蜗植入,机构再植入率为2.9%,文献汇总再植入率为6.0%;装置故障占1.6%、医疗故障占0.5%、结论不明确故障占0.7%;生存分析显示不同制造商间存在显著差异,成人装置故障率(0.8%)低于儿童(2.8%)。
要点
- 机构再植入率2.9%,文献汇总再植入率6.0%。
- 装置故障占1.6%,医疗故障占0.5%,结论不明确故障占0.7%。
- 生存分析显示不同制造商间存在显著差异,成人装置故障率0.8%低于儿童2.8%。
核心结论
- 这项30年回顾是文献中考察再植入、装置故障和医疗故障率的最长系列之一;人工耳蜗生存率因制造商而异,成人的装置故障率显著优于儿童。
研究设计与样本
- 回顾性机构经验与文献综述;回顾单中心1988年1月至2017年3月30年间的人工耳蜗故障,共804例人工耳蜗植入,来自三家制造商。
- 通过PubMed、Web of Science和EMBASE数据库电子检索获得24篇关于人工耳蜗装置故障的文献,提取再植入率和装置故障率数据进行分析。
- 使用Kaplan-Meier曲线进行生存分析。
主要发现
- 机构再植入率为2.9%,文献综述汇总的再植入率为6.0%。
- 医疗故障占总体故障的0.5%,装置故障占1.6%,结论不明确的故障占0.7%。
- 生存分析显示不同制造商之间存在显著差异。
- 成人人群的装置故障率(0.8%)较儿童人群(2.8%)改善。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: The objectives of the study were to present an institutional experience with device failures and cochlear reimplantation rates over a 30-year period and to perform a detailed literature review. STUDY DESIGN: Retrospective institutional experience and literature review. METHODS: A review of cochlear implant failures over a period of 30 years, between January 1988 and March 2017, at a single institution was conducted. Cochlear implant failures were calculated based on manufacturer, type of failure, and overall failure rate. Survival analysis was performed using Kaplan-Meier curves. An electronic search of the PubMed, Web of Science, and EMBASE databases revealed 24 articles on the topic of cochlear device failure. Data on reimplantation and device failure rates were extracted from this literature review and analyzed. RESULTS: A total of 804 cochlear implantations were reviewed from three manufacturers. The institutional reimplantation rate was 2.9% compared to the pooled rate of 6.0% calculated from the literature review. Medical failures accounted for 0.5% of the overall failures, device failures accounted for 1.6%, and inconclusive failures account for 0.7%. Survival analysis revealed a significant difference among manufacturers. An improved device failure rate was noted in the adult population (0.8%) as compared to the pediatric population (2.8%). CONCLUSIONS: This 30-year review represents one of the longest series in the literature examining reimplantation, device failure, and medical failure rates. Cochlear implant survival varied by manufacturer and was significantly better in adult compared to pediatric patients. LEVEL OF EVIDENCE: NA Laryngoscope, 130:782-789, 2020.
引用
- Lane C, Zimmerman K, Agrawal S, et al. Cochlear implant failures and reimplantation: A 30-year analysis and literature review. Laryngoscope. 2019. PMID: 31112331. doi:10.1002/lary.28071
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。